
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$294.8m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.69
7D
-4.8%
1Y
616.5%
Neuren Pharmaceuticals
Market Cap: AU$2.1b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$17.29
7D
-1.4%
1Y
12.3%